Pfizer Birth Control Recall
Written by Faith Anderson on February 2, 2012
Birth Control Pills Recalled Due to Serious Packaging Error
According to Pfizer, the packaging problems affects fourteen lots of Lo/Ovral-28 tablets and fourteen lots of generic norgestrel and ethinyl estradiol tablets. Both affected products are manufactured by Pfizer and marketed in the United States by Akrimax Rx Products. Pfizer discovered that some of the packets had too many active tablets, while others had too few. Oral birth control pills like the ones affected by this recall use a series of twenty-one drug tablets and seven inactive sugar tablets to regulate the menstrual period while providing contraception. The pills are typically color-coded to note the difference.
Oral Contraceptive Failure May Result in Unwanted Pregnancy
A spokeswoman for Pfizer said the problem was caused by both visual and mechanical inspection failures on the packaging line, problems which have since been corrected. Pfizer, the largest pharmaceutical company in the world, issued a statement saying the problem is not related to safety, but does raise the risk of unintended pregnancy. Doctors say taking three placebo tablets or more in a row negates the pregnancy protection. “Women who are potentially on this particular product need to be aware of [the recall] and take this quite seriously,” said Dr. Steven R. Goldstein, a New York University professor of obstetrics and gynecology. Patients who received a packet from one of the affected lots should call their doctors immediately; if they have had unprotected sex in the past five days while on one of these pill packets, they may want to consider emergency contraception.